This article explores the challenges faced in a clinical trial comparing electronic cigarettes and Varenicline as methods for quitting smoking. It emphasizes the importance of comprehensive data collection for effective public health strategies.
Understanding the gaps in such research helps policymakers, healthcare providers, and researchers improve smoking cessation interventions and address public health concerns more effectively.